학술논문

UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – A phase II randomised trial
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, May 2024, 202)
Subject
Language
English
ISSN
18790852
09598049